Physician profile
Gary M Hall
NPI 1558378471
$647.06
in general payments reported to CMS, 2019-2025
15 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.34 · 2020: $30.65 · 2021: $71.41 · 2022: $103 · 2023: $78.57 · 2024: $99.45 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $142.76 | 2019-2025 | Stravix Pl, Grafix Pl |
| Intuitive Surgical, INC. | $126.70 | 2021-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $54.91 | 2021 | |
| Davol INC. | $41.93 | 2023 | Phasix Mesh |
| Abbott Laboratories | $37.34 | 2019 | |
| Integra Lifesciences Corporation | $37.21 | 2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Allergan, INC. | $31.89 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $30.51 | 2025 | |
| Tela Bio, INC. | $27.33 | 2020-2024 | Ovitex 2s |
| Innovation Technologies INC | $26.87 | 2024 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $24.86 | 2025 | Exparel |
| Teleflex LLC | $18.05 | 2019 | |
| Boston Scientific Corporation | $17.14 | 2025 | Spyglass Discover |
| Baxter Healthcare | $15.87 | 2022 | |
| Lsi Solutions INC | $13.69 | 2023 | Ti Knot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.